• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蓝色视锥细胞单色视:临床试验的视觉功能和疗效结局指标

Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials.

作者信息

Luo Xunda, Cideciyan Artur V, Iannaccone Alessandro, Roman Alejandro J, Ditta Lauren C, Jennings Barbara J, Yatsenko Svetlana A, Sheplock Rebecca, Sumaroka Alexander, Swider Malgorzata, Schwartz Sharon B, Wissinger Bernd, Kohl Susanne, Jacobson Samuel G

机构信息

Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Hamilton Eye Institute, Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.

出版信息

PLoS One. 2015 Apr 24;10(4):e0125700. doi: 10.1371/journal.pone.0125700. eCollection 2015.

DOI:10.1371/journal.pone.0125700
PMID:25909963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4409040/
Abstract

BACKGROUND

Blue Cone Monochromacy (BCM) is an X-linked retinopathy caused by mutations in the OPN1LW / OPN1MW gene cluster, encoding long (L)- and middle (M)-wavelength sensitive cone opsins. Recent evidence shows sufficient structural integrity of cone photoreceptors in BCM to warrant consideration of a gene therapy approach to the disease. In the present study, the vision in BCM is examined, specifically seeking clinically-feasible outcomes for a future clinical trial.

METHODS

BCM patients (n = 25, ages 5-72) were studied with kinetic and static chromatic perimetry, full-field sensitivity testing, and eye movement recordings. Vision at the fovea and parafovea was probed with chromatic microperimetry.

RESULTS

Kinetic fields with a Goldmann size V target were generally full. Short-wavelength (S-) sensitive cone function was normal or near normal in most patients. Light-adapted perimetry results on conventional background lights were abnormally reduced; 600-nm stimuli were seen by rods whereas white stimuli were seen by both rods and S-cones. Under dark-adapted conditions, 500-nm stimuli were seen by rods in both BCM and normals. Spectral sensitivity functions in the superior retina showed retained rod and S-cone functions in BCM under dark-adapted and light-adapted conditions. In the fovea, normal subjects showed L/M-cone mediation using a 650-nm stimulus under dark-adapted conditions, whereas BCM patients had reduced sensitivity driven by rod vision. Full-field red stimuli on bright blue backgrounds were seen by L/M-cones in normal subjects whereas BCM patients had abnormally reduced and rod-mediated sensitivities. Fixation location could vary from fovea to parafovea. Chromatic microperimetry demonstrated a large loss of sensitivity to red stimuli presented on a cyan adapting background at the anatomical fovea and surrounding parafovea.

CONCLUSIONS

BCM rods continue to signal vision under conditions normally associated with daylight vision. Localized and retina-wide outcome measures were examined to evaluate possible improvement of L/M-cone-based vision in a clinical trial.

摘要

背景

蓝锥单色素视(BCM)是一种X连锁视网膜病变,由编码长(L)和中(M)波长敏感视锥蛋白的OPN1LW / OPN1MW基因簇突变引起。最近的证据表明,BCM中视锥光感受器具有足够的结构完整性,值得考虑采用基因治疗方法来治疗该疾病。在本研究中,对BCM患者的视力进行了检查,特别寻找未来临床试验中临床可行的结果。

方法

对25例BCM患者(年龄5 - 72岁)进行了动态和静态色觉视野检查、全视野敏感度测试以及眼动记录。用彩色微视野计探测中央凹和旁中央凹的视力。

结果

使用戈德曼V型视标测得的动态视野通常完整。大多数患者的短波(S)敏感视锥功能正常或接近正常。在传统背景光下的明适应视野检查结果异常降低;600纳米刺激由视杆细胞感知,而白色刺激由视杆细胞和S视锥细胞共同感知。在暗适应条件下,BCM患者和正常受试者的视杆细胞均能感知500纳米刺激。在暗适应和明适应条件下,BCM患者视网膜上部的光谱敏感度函数显示视杆细胞和S视锥细胞功能保留。在中央凹,正常受试者在暗适应条件下使用650纳米刺激时显示L/M视锥细胞介导,而BCM患者由视杆细胞视觉驱动的敏感度降低。正常受试者在亮蓝色背景下的全视野红色刺激由L/M视锥细胞感知,而BCM患者的敏感度异常降低且由视杆细胞介导。注视位置可能从中央凹变化到旁中央凹。彩色微视野计显示,在解剖学中央凹和周围旁中央凹处,在青色适应背景下呈现的红色刺激的敏感度大幅下降。

结论

在通常与明视觉相关的条件下,BCM视杆细胞继续传递视觉信号。检查了局部和全视网膜的结果指标,以评估在临床试验中基于L/M视锥细胞的视力可能得到的改善。

相似文献

1
Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials.蓝色视锥细胞单色视:临床试验的视觉功能和疗效结局指标
PLoS One. 2015 Apr 24;10(4):e0125700. doi: 10.1371/journal.pone.0125700. eCollection 2015.
2
Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy.评估蓝色视锥单色症的视网膜结构和视觉功能,为 L-opsin 基因治疗开发临床终点。
Int J Mol Sci. 2024 Oct 2;25(19):10639. doi: 10.3390/ijms251910639.
3
Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy.人类L-视蛋白和M-视蛋白在人类蓝锥单色视的小鼠模型中恢复了M-视锥细胞功能。
Mol Vis. 2018 Jan 8;24:17-28. eCollection 2018.
4
Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy.基于基因的治疗在蓝色锥体单色性的小鼠模型中。
Sci Rep. 2017 Jul 27;7(1):6690. doi: 10.1038/s41598-017-06982-7.
5
Gene Therapy in Mice and Implications for Blue Cone Monochromacy Patients with Deletion Mutations.基因治疗在小鼠中的应用及对缺失突变型蓝色锥体细胞单色症患者的启示。
Hum Gene Ther. 2022 Jul;33(13-14):708-718. doi: 10.1089/hum.2021.298. Epub 2022 May 16.
6
Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures.量化视网膜变性中视杆光感受器介导的视觉:以暗适应阈值作为结果指标。
Exp Eye Res. 2005 Feb;80(2):259-72. doi: 10.1016/j.exer.2004.09.008.
7
Threshold versus intensity functions in two-colour automated perimetry.双色自动视野计中的阈值与强度函数。
Ophthalmic Physiol Opt. 2021 Jan;41(1):157-164. doi: 10.1111/opo.12743. Epub 2020 Oct 16.
8
The application of chromatic dark-adapted kinetic perimetry to retinal diseases.彩色暗适应动态视野检查法在视网膜疾病中的应用。
Ophthalmology. 2004 Jun;111(6):1222-7. doi: 10.1016/j.ophtha.2003.10.025.
9
Two-color pupillometry in enhanced S-cone syndrome caused by NR2E3 mutations.由NR2E3突变引起的增强型S-视锥细胞综合征中的双色瞳孔测量法。
Doc Ophthalmol. 2016 Jun;132(3):157-66. doi: 10.1007/s10633-016-9535-0. Epub 2016 Mar 31.
10
Blue Cone Monochromacy Caused by the C203R Missense Mutation or Large Deletion Mutations.蓝色 Cone 单色症由 C203R 错义突变或大片段缺失突变引起。
Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5762-5772. doi: 10.1167/iovs.18-25280.

引用本文的文献

1
Molecular Mechanisms Limiting the Therapeutic Window of AAV Gene Therapy in Mouse Models of Blue Cone Monochromacy.限制蓝锥单色性小鼠模型中腺相关病毒基因治疗治疗窗口的分子机制
Res Sq. 2025 Apr 7:rs.3.rs-6075007. doi: 10.21203/rs.3.rs-6075007/v1.
2
Molecular Mechanisms Limiting the Therapeutic Window of AAV Gene Therapy in Mouse Models of Blue Cone Monochromacy.限制蓝锥单色性小鼠模型中腺相关病毒基因治疗治疗窗口的分子机制
bioRxiv. 2025 Feb 16:2025.02.14.638316. doi: 10.1101/2025.02.14.638316.
3
Retinal Degeneration Associated With Biallelic RDH12 Variants: Longitudinal Evaluation of Retinal Structure and Visual Function in Pediatric Patients.

本文引用的文献

1
Pseudo-fovea formation after gene therapy for RPE65-LCA.RPE65基因疗法治疗莱伯先天性黑蒙后的假黄斑形成。
Invest Ophthalmol Vis Sci. 2014 Dec 23;56(1):526-37. doi: 10.1167/iovs.14-15895.
2
Three different cone opsin gene array mutational mechanisms with genotype-phenotype correlation and functional investigation of cone opsin variants.三种不同的视锥视蛋白基因阵列突变机制及其基因型-表型相关性和视锥视蛋白变体的功能研究。
Hum Mutat. 2014 Nov;35(11):1354-62. doi: 10.1002/humu.22679.
3
S-cone psychophysics.S 视锥细胞心理物理学
与双等位基因RDH12变异相关的视网膜变性:儿科患者视网膜结构和视觉功能的纵向评估
Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):30. doi: 10.1167/iovs.65.14.30.
4
Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy.评估蓝色视锥单色症的视网膜结构和视觉功能,为 L-opsin 基因治疗开发临床终点。
Int J Mol Sci. 2024 Oct 2;25(19):10639. doi: 10.3390/ijms251910639.
5
Update on Clinical Trial Endpoints in Gene Therapy Trials for Inherited Retinal Diseases.遗传性视网膜疾病基因治疗试验的临床试验终点更新
J Clin Med. 2024 Sep 18;13(18):5512. doi: 10.3390/jcm13185512.
6
Dyschromatopsia: a comprehensive analysis of mechanisms and cutting-edge treatments for color vision deficiency.色盲:色觉缺陷的机制与前沿治疗方法综合分析
Front Neurosci. 2024 Jan 17;18:1265630. doi: 10.3389/fnins.2024.1265630. eCollection 2024.
7
Full-field stimulus threshold testing: a scoping review of current practice.全场刺激阈值测试:当前实践的范围综述。
Eye (Lond). 2024 Jan;38(1):33-53. doi: 10.1038/s41433-023-02636-3. Epub 2023 Jul 13.
8
Blue cone monochromacy and gene therapy.蓝色锥细胞单色视症与基因治疗。
Vision Res. 2023 Jul;208:108221. doi: 10.1016/j.visres.2023.108221. Epub 2023 Mar 29.
9
Preclinical evaluation of ADVM-062, a novel intravitreal gene therapy vector for the treatment of blue cone monochromacy.ADVM-062 的临床前评估,一种新型的治疗蓝色锥细胞单色症的眼内基因治疗载体。
Mol Ther. 2023 Jul 5;31(7):2014-2027. doi: 10.1016/j.ymthe.2023.03.011. Epub 2023 Mar 16.
10
Color Vision in Blue Cone Monochromacy: Outcome Measures for a Clinical Trial.蓝锥单色症的色觉:临床试验的结果评估。
Transl Vis Sci Technol. 2023 Jan 3;12(1):25. doi: 10.1167/tvst.12.1.25.
Vis Neurosci. 2014 Mar;31(2):211-25. doi: 10.1017/S0952523814000030.
4
Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy.人类视锥细胞视觉色素缺失保留了足够的光感受器,使基因治疗具有可行性。
Hum Gene Ther. 2013 Dec;24(12):993-1006. doi: 10.1089/hum.2013.153. Epub 2013 Oct 30.
5
In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous.玻璃体腔给药治疗性外层视网膜的新型腺相关病毒的活体定向进化。
Sci Transl Med. 2013 Jun 12;5(189):189ra76. doi: 10.1126/scitranslmed.3005708.
6
Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.通过使用新型、衣壳突变的 AAV 载体经玻璃体腔递送来靶向感光细胞。
PLoS One. 2013 Apr 26;8(4):e62097. doi: 10.1371/journal.pone.0062097. Print 2013.
7
A comprehensive review of retinal gene therapy.视网膜基因治疗的全面综述。
Mol Ther. 2013 Mar;21(3):509-19. doi: 10.1038/mt.2012.280. Epub 2013 Jan 29.
8
Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations.RPE65 基因突变致莱伯先天性黑矇的视觉参数的随访间变异性。
Invest Ophthalmol Vis Sci. 2013 Feb 15;54(2):1378-83. doi: 10.1167/iovs.12-11341.
9
The effect of cone opsin mutations on retinal structure and the integrity of the photoreceptor mosaic.视锥蛋白突变对视网膜结构和光感受器嵌合体完整性的影响。
Invest Ophthalmol Vis Sci. 2012 Dec 5;53(13):8006-15. doi: 10.1167/iovs.12-11087.
10
Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutants.确定视网膜膜鸟苷酸环化酶(RetGC1)缺乏对人类先天性黑蒙 Leber 的影响,以寻求治疗方法:残余的视锥细胞感光功能与突变体的生化特性相关。
Hum Mol Genet. 2013 Jan 1;22(1):168-83. doi: 10.1093/hmg/dds421. Epub 2012 Oct 3.